XBI Short Interest
State Street SPDR S&P Biotech ETF (XBI) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $8.35B, listed on AMEX, carrying a beta of 1.09 to the broader market. The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing public since 2006-02-06.
Short interest is the total number of shares currently sold short and not yet covered, reported bi-monthly by FINRA. Days to cover (short interest divided by average daily volume) indicates how long it would take short sellers to close positions, with higher values signaling greater squeeze potential.
- Settlement Date
- 2026-04-30
- Short Interest
- 74.8M
- Previous Short Interest
- 73.3M
- Change
- 1.94%
- Days to Cover
- 10.24
- Avg Daily Volume
- 7.3M
- Avg Days to Cover (24 reports)
- 7.77
Showing 24 bi-monthly FINRA short interest reports for State Street SPDR S&P Biotech ETF.
Learn how short interest is reported and how to read the data →
Frequently asked XBI short interest questions
- What is the current XBI short interest?
- As of the Apr 30, 2026 settlement, State Street SPDR S&P Biotech ETF (XBI) short interest is 74.8M shares, a +1.94% change from the prior period. FINRA publishes short interest twice monthly on the 15th and last business day of each month under Rule 4560.
- What is the XBI days-to-cover ratio?
- Days-to-cover is 10.24, calculated as short interest divided by average daily volume. It estimates how many trading days closing all short positions would consume given typical liquidity. Values above 5 days are commonly cited as elevated; values above 10 days are squeeze-relevant.
- How does XBI short interest affect options pricing?
- High short interest changes options pricing through three mechanics: borrow-rebate effects (synthetic long stock trades below frictionless put-call parity by approximately the borrow rebate when shares are hard-to-borrow), gamma-squeeze setup risk (if dealers are short gamma against retail call buying, dealer hedge flow can amplify upward moves), and elevated event-vol pricing on names with squeeze potential. See the canonical short-interest documentation for the full mechanism.